Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 6, 1999, Pages 1441-1444

  Girgis, Nabil I ^a   Butler, Thomas ^b,e   Frenck, Robert W ^a   Sultan, Yehia ^c   Brown, Forrest M ^a   Tribble, David ^a   Khakhria, Rasik ^d  

^a US Naval Medical Research Unit No 3 Egypt   (Egypt)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c ABBASSIA FEVER HOSPITAL   (Egypt)

^d Bureau of Microbiology   (Canada)

^e TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BLOOD CULTURE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SALMONELLA PARATYPHI; SALMONELLA TYPHI; TREATMENT OUTCOME; TYPHOID FEVER;

EID: 0033042437     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.6.1441     Document Type: Article

References (22)

1. Acharya, G., T. Butler, M. Ho, P. R. Sharma, M. Tiwari, R. K. Adhikari, J. B. Khagda, B. Pokhrel, and U. N. Pathak. 1995. Treatment of typhoid fever: randomized trial of a three-day course of cefriaxone versus a fourteen-day course of chloramphenicol. Am. J. Trop. Med. Hyg. 52:162-165.
2. Azad, A. K., R. Islam, M. A. Salam, A. N. Alam, and T. Butler. 1997. Comparison of clinical features and pathologic findings in fatal cases of typhoid fever during the initial and later stages of the disease. Am. J. Trop. Med. Hyg. 56:490-493.
3. Bhutta, Z. A., I. A. Khan, and A. M. Molla. 1994. Therapy of multi-drug resistant typhoid fever with oral cefixime vs intravenous ceftriaxone. Pediatr. Infect. Dis. J. 13:990-994.
4. Butler, T., and A. E. Girard. 1993. Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in mice. J. Antimicrob. Chemother. 31:313-319.
5. Butler, T., A. Islam, I. Kabir, and P. K. Jones. 1991. Patterns of morbidity and mortality in typhoid fever dependent on age and gender: review of 552 hospitalized patients with diarrhea. Rev. Infect. Dis. 13:85-90.
6. Butler, T., C. Sridhar, M. Daga, K. Jani, R. Pandit, R. Khakhria, C. Potkar, and R. Johnson. 1997. Azithromycin vs. chloramphenicol in the treatment of typhoid fever in India, abstr. LM-18, p. 367. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
7. Dutta, P., R. Rasaily, M. R. Saha, U. Mitra, B. Manna, S. Chakraborty, and A. Mukherjee. 1993. Randomized clinical trial of furazolidone for typhoid fever in children. Scand. J. Gastroenterol. 28:168-172.
8. Girgis, N. I., M. E. Kilpatrick, Z. Farid, Y. Sultan, and J. K. Podgore. 1993. Cefixime in the treatment of enteric fever in children. Drugs Exp. Clin. Res. 19:47-49.
9. Girgis, N. I., Y. Sultan, O. Hammad, and Z. Farid. 1995. Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug resistant Salmonella typhi septicemia in children. Pediatr. Infect. Dis. J. 14:603-605.
10. Khakhria, R., D. Woodward, W. M. Johnson, and C. Poppe. 1997. Salmonella isolated from humans, animals and other sources in Canada, 1983-92. Epidemiol. Infect. 119:15-23.
11. Metchock, B. 1990. In vitro activity of azithromycin compared with other macrolides and oral antibiotics against Salmonella typhi. J. Antimicrob. Chemother. 24(Suppl. A):29-31.
12. Mirza, S. H., N. J. Beeching, and C. A. Hart. 1996. Multi-drug resistant typhoid fever: a global problem. J. Med. Microbiol. 44:317-319.
13. Pascual, A., M. C. Conejo, I. Garcia, and E. J. Perea. 1995. Factors affecting the intracellular accumulation and activity of azithromycin. J. Antimicrob. Chemother. 35:85-93.
14. Retsema, J., A. Girard, W. Schelky, M. Manousos, M. Anderson, and G. Bright. 1987. Spectrum and mode of action of azithromycin (CP-62, 993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob. Agents Chemother. 31:1939-1947.
15. Rowe, B., L. R. Ward, and E. J. Trelfall. 1997. Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin. Infect. Dis. 24(Suppl. 1):S106-S109.
16. Smith, M. D., N. M. Duong, N. T. Hoa, J. Wain, H. D. Ha, T. S. Diep, N. P. J. Day, T. T. Hien, and N. J. White. 1994. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrob. Agents Chemother. 38:1716-1720.
17. Threlfall, E. J., A. Graham, T. Cheasty, L. R. Ward, and B. Rowe. 1997. Resistance to ciprofloxacin in pathogenic Enterobacteriaceae in England and Wales in 1996. J. Clin. Pathol. 50:1027-1028.
18. Tribble, D., N. Girgis, N. Habib, and T. Butler. 1995. Efficacy of azithromycin for typhoid fever. Clin. Infect. Dis. 21:1045-1046.
19. Wain, J., N. T. T. Hoa, N. T. Chinh, H. Vinh, M. J. Everett, T. S. Diep, N. P. J. Day, T. Solomon, N. J. White, L. J. V. Piddock, and C. M. Parry. 1997. Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin. Infect. Dis. 25:1404-1410.
20. Wallace, M. R., A. A. Yousif, G. A. Mahroos, T. Mapes, E. J. Threlfall, B. Rowe, and K. C. Hyams. 1994. Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever. Eur. J. Clin. Microbiol. Infect. Dis. 12:907-910.
21. Wildfeuer, A., H. Laufen, and T. Zimmerman. 1996. Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions. Antimicrob. Agents Chemother. 40:75-79.
22. Young, M. J., E. A. Bresnitz, and B. L. Strom. 1983. Sample size nomograms for interpreting negative clinical studies. Ann. Intern. Med. 99:248-251.